Price
Financials
Standalone, Rs crore| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 16.04 | 22.22 | 14.20 | 15.52 | 20.54 | 17.75 | 12.37 | 12.70 | 14.16 | 10.58 | 16.20 | 9.10 |
| Expenses | 12.91 | 17.39 | 12.32 | 12.90 | 15.82 | 12.92 | 12.55 | 10.76 | 14.29 | 9.49 | 16.87 | 10.79 |
| Operating Profit | 3.13 | 4.83 | 1.88 | 2.62 | 4.72 | 4.83 | -0.18 | 1.94 | -0.13 | 1.09 | -0.67 | -1.69 |
| OPM % | 19.51% | 21.74% | 13.24% | 16.88% | 22.98% | 27.21% | -1.46% | 15.28% | -0.92% | 10.30% | -4.14% | -18.57% |
| Other Income | 1.53 | 1.51 | 1.59 | 1.52 | 1.14 | 2.04 | 2.01 | 1.77 | 2.65 | 1.85 | 2.96 | 2.26 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.47 | 0.48 | 0.54 | 0.49 | 0.49 | 0.50 | 0.50 | 0.45 | 0.47 | 0.48 | 0.59 | 0.62 |
| Profit before tax | 4.19 | 5.86 | 2.93 | 3.65 | 5.37 | 6.37 | 1.33 | 3.26 | 2.05 | 2.46 | 1.70 | -0.05 |
| Tax % | 25.30% | 26.79% | 28.67% | 24.93% | 25.51% | 25.75% | 28.57% | 25.46% | 25.85% | 26.02% | 31.76% | -20.00% |
| Net Profit | 3.14 | 4.29 | 2.10 | 2.73 | 3.99 | 4.74 | 0.94 | 2.43 | 1.52 | 1.82 | 1.15 | -0.04 |
| EPS in Rs | 3.06 | 4.19 | 2.05 | 2.66 | 3.89 | 4.62 | 0.92 | 2.37 | 1.48 | 1.78 | 1.12 | -0.04 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 54.08 | 42.61 | 51.60 | 53.95 | 73.70 | 78.24 | 62.27 | 75.39 | 69.51 | 65.47 | 53.63 | 50.04 |
| Expenses | 51.16 | 36.62 | 42.57 | 44.78 | 52.31 | 53.52 | 51.30 | 59.24 | 56.86 | 54.18 | 51.39 | 51.44 |
| Operating Profit | 2.92 | 5.99 | 9.03 | 9.17 | 21.39 | 24.72 | 10.97 | 16.15 | 12.65 | 11.29 | 2.24 | -1.40 |
| OPM % | 5.40% | 14.06% | 17.50% | 17.00% | 29.02% | 31.60% | 17.62% | 21.42% | 18.20% | 17.24% | 4.18% | -2.80% |
| Other Income | 1.68 | 1.89 | 1.69 | 2.52 | 3.68 | 3.75 | 3.46 | 4.71 | 5.92 | 7.42 | 9.22 | 9.72 |
| Interest | 0.29 | 0.08 | 0.01 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 1.76 | 1.87 | 1.85 | 1.84 | 1.74 | 1.72 | 1.79 | 1.77 | 1.94 | 1.99 | 2.00 | 2.16 |
| Profit before tax | 2.55 | 5.93 | 8.86 | 9.85 | 23.33 | 26.74 | 12.64 | 19.09 | 16.63 | 16.72 | 9.46 | 6.16 |
| Tax % | 3.53% | 48.06% | 33.86% | 27.41% | 24.73% | 25.24% | 26.11% | 25.72% | 26.40% | 25.72% | 26.74% | |
| Net Profit | 2.47 | 3.08 | 5.86 | 7.15 | 17.56 | 19.98 | 9.33 | 14.17 | 12.24 | 12.41 | 6.94 | 4.45 |
| EPS in Rs | 2.41 | 3.00 | 5.72 | 6.98 | 17.13 | 19.49 | 9.10 | 13.82 | 11.94 | 12.11 | 6.77 | 4.34 |
| Dividend Payout % | 20.71% | 16.61% | 8.75% | 7.17% | 0.00% | 5.13% | 16.48% | 0.00% | 20.94% | 24.78% | 51.69% |
| 10 Years | 5 Years | 3 Years | TTM | 1 Year | Last Year | |
|---|---|---|---|---|---|---|
| Compounded Sales Growth | 0% | -7% | -11% | -21% | ||
| Compounded Profit Growth | 11% | -20% | -21% | -65% | ||
| Stock Price CAGR | 5% | -14% | -16% | -24% | ||
| Return on Equity | 12% | 9% | 8% | 5% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 10.23 | 10.23 | 10.23 | 10.25 | 10.25 | 10.25 | 10.25 | 10.25 | 10.25 | 10.25 | 10.25 | 10.25 |
| Reserves | 33.56 | 35.36 | 37.66 | 42.88 | 50.02 | 66.93 | 85.72 | 93.97 | 106.51 | 116.49 | 126.46 | 130.23 |
| Borrowings | 8.68 | 10.83 | 0.00 | 0.07 | 0.04 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Liabilities | 11.51 | 11.01 | 13.10 | 13.52 | 13.70 | 17.52 | 20.98 | 16.05 | 19.95 | 7.95 | 10.69 | 7.56 |
| Total Liabilities | 63.98 | 67.43 | 60.99 | 66.72 | 74.01 | 94.70 | 116.95 | 120.27 | 136.71 | 134.69 | 147.40 | 148.04 |
| Fixed Assets | 28.98 | 28.40 | 26.57 | 19.84 | 19.15 | 17.67 | 17.93 | 16.63 | 16.61 | 17.90 | 16.48 | 18.88 |
| CWIP | 0.38 | 0.33 | 0.33 | 0.00 | 0.00 | 0.00 | 0.53 | 0.00 | 0.00 | 0.00 | 0.16 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 34.62 | 38.70 | 34.09 | 46.88 | 54.86 | 77.03 | 98.49 | 103.64 | 120.10 | 116.79 | 130.76 | 129.16 |
| Total Assets | 63.98 | 67.43 | 60.99 | 66.72 | 74.01 | 94.70 | 116.95 | 120.27 | 136.71 | 134.69 | 147.40 | 148.04 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | 2.31 | 11.96 | 11.37 | 5.04 | 3.75 | 15.21 | 15.45 | 4.46 | 6.43 | 7.71 | 8.54 | 2.85 |
| Cash from Investing Activity | -0.98 | -1.34 | 0.60 | 6.29 | 0.63 | 2.04 | 0.42 | 3.16 | -3.12 | 3.94 | -0.39 | -8.95 |
| Cash from Financing Activity | -3.24 | 1.59 | -10.59 | -0.60 | -0.07 | -0.62 | -1.02 | -1.02 | -1.54 | -2.05 | -2.56 | -3.07 |
| Net Cash Flow | -1.90 | 12.20 | 1.38 | 10.72 | 4.31 | 16.63 | 14.85 | 6.59 | 1.77 | 9.61 | 5.59 | -9.17 |
| Free Cash Flow | 1.33 | 10.82 | 11.33 | 10.25 | 2.61 | 14.95 | 12.95 | 4.58 | 4.68 | 4.48 | 7.84 | -1.39 |
| CFO/OP | 33% | 410% | 190% | 56% | 41% | 71% | 62% | 41% | 40% | 61% | 76% | 127% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 90.65 | 106.71 | 81.12 | 68.05 | 68.81 | 64.04 | 79.91 | 96.25 | 106.90 | 100.40 | 95.45 | 132.99 |
| Inventory Days | 138.26 | 67.76 | 83.68 | 85.37 | 122.85 | 121.71 | 148.08 | 148.32 | 195.21 | 157.11 | 244.61 | 149.93 |
| Days Payable | 75.69 | 92.82 | 130.50 | 86.81 | 95.79 | 91.41 | 93.04 | 77.86 | 134.49 | 47.91 | 85.26 | 37.78 |
| Cash Conversion Cycle | 153.22 | 81.65 | 34.30 | 66.61 | 95.87 | 94.34 | 134.95 | 166.71 | 167.62 | 209.60 | 254.79 | 245.13 |
| Working Capital Days | 77.39 | 21.46 | 60.48 | 66.63 | 86.53 | 77.11 | 82.76 | 121.22 | 128.74 | 144.30 | 149.58 | 177.43 |
| ROCE % | 7.37% | 5.22% | 11.52% | 17.55% | 17.36% | 33.92% | 32.04% | 13.32% | 17.39% | 13.66% | 12.68% | 6.83% |
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 61.97% | 61.97% | 61.97% | 61.97% | 61.97% | 61.97% | 61.97% | 61.97% | 62.06% | 61.97% | 61.97% | 61.97% |
| Public | 38.04% | 38.04% | 38.03% | 38.03% | 38.03% | 38.03% | 38.03% | 38.03% | 37.95% | 38.03% | 38.03% | 38.03% |
| No. of Shareholders | 8,461 | 8,221 | 7,867 | 7,477 | 7,264 | 7,308 | 7,425 | 7,376 | 7,257 | 7,152 | 6,952 | 6,786 |
Fundamentals
Market Cap₹ 108 Cr.
Current Price₹ 106
Stock P/E24.4
Book Value₹ 137
ROCE6.83 %
ROE5.01 %
Dividend Yield3.31 %
Face Value₹ 10.0
Compounded Sales Growth (TTM)-21%
Compounded Profit Growth (TTM)-65%
Standalone figures.
Valuation
Market capRs 108 Cr
Enterprise valueRs 32 Cr
P/E (TTM)24.16x
Price to book0.77x
Price to sales2.15x
EV / EBITDA3.87x
EV / EBIT5.23x
EV / sales0.64x
Price to cash flow37.73x
Earnings yield4.14%
Dividend yield3.34%
P/E, 3-year average13.48x
P/B, 3-year average1.05x
P/E, 5-year average13.14x
P/B, 5-year average1.15x
Profitability
Operating margin (excl. other income)4.18%
Operating margin (incl. other income)21.37%
EBITDA margin16.63%
Pre-tax margin12.31%
Net profit margin8.89%
Net margin, latest quarter-0.44%
ROE5.01%
ROCE6.83%
ROA4.70%
ROE, 3-year average8.16%
ROCE, 3-year average11.06%
ROA, 3-year average7.51%
ROE, 5-year average9.33%
ROCE, 5-year average12.62%
ROA, 5-year average8.28%
ROIC (approx.)6.93%
Tax rate26.74%
Other income / net worth6.56%
Growth
Sales growth (latest year)-18.08%
Profit growth (latest year)-44.08%
Sales CAGR, 3 years-10.73%
Sales CAGR, 5 years-7.28%
Profit CAGR, 3 years-21.18%
Profit CAGR, 5 years-19.06%
Sales growth QoQ-43.83%
Profit growth QoQ-103.48%
Sales growth YoY (latest quarter)-28.35%
Profit growth YoY (latest quarter)-101.65%
Per share
EPS (TTM)Rs 4.34
EPS (latest year)Rs 6.77
EPS (latest quarter)Rs -0.04
EPS, 3-year averageRs 10.28
EPS, 5-year averageRs 10.75
Book value per shareRs 137.12
Sales per shareRs 48.84
Cash flow per shareRs 2.78
Free cash flow per shareRs -1.36
Dividend per share (latest year)Rs 3.50
Dividend per share, 3-year averageRs 3.00
Dividend per share, 5-year averageRs 2.63
Dividends
Dividend payout51.73%
Dividend payout, 3-year average32.49%
Dividend payout, 5-year average28.49%
Efficiency
Asset turnover0.36x
Fixed asset turnover2.84x
Inventory turnover3.53x
Inventory days103 days
Debtor days133 days
Debtors turnover2.74x
Creditor days38 days
Cash conversion cycle245 days
Working capital days177 days
Leverage
Cash and bankRs 75 Cr
Net debtRs -75 Cr
Net debt / EBITDA-9.05x
Owners' fund to total sources94.89%
Cash flow
Cash from Operating Activity (latest year)Rs 3 Cr
Cash from Investing Activity (latest year)Rs -9 Cr
Cash from Financing Activity (latest year)Rs -3 Cr
Net Cash Flow (latest year)Rs -9 Cr
Free cash flow (latest year)Rs -1 Cr
Cash from ops / profit, 5 years0.54x
Sales to cash flow18.82x
Statement figures
Net sales (TTM)Rs 50 Cr
Net sales (latest year)Rs 54 Cr
Sales (latest quarter)Rs 9 Cr
Operating profit excl. other income (latest year)Rs 2 Cr
Operating profit (latest quarter)Rs -2 Cr
Other income (TTM)Rs 10 Cr
EBITDA (TTM)Rs 8 Cr
PBDT (TTM)Rs 8 Cr
Profit before tax (TTM)Rs 6 Cr
Tax (latest year)Rs 3 Cr
Net profit (TTM)Rs 4 Cr
Net profit (latest year)Rs 7 Cr
Net profit (latest quarter)Rs -0 Cr
Depreciation (TTM)Rs 2 Cr
Depreciation (latest quarter)Rs 1 Cr
Cost of goods sold (latest year)Rs 35 Cr
Total expenditure (latest year)Rs 51 Cr
Total income (latest year)Rs 63 Cr
Share capitalRs 10 Cr
ReservesRs 130 Cr
Shareholders' fundsRs 140 Cr
Total assetsRs 148 Cr
Net blockRs 19 Cr
ReceivablesRs 20 Cr
InventoryRs 10 Cr
Other liabilitiesRs 8 Cr
Shares outstanding (crore)1.02
Ownership
Promoter holding61.97% (+0.00 in a year)
Computed by MarketFriction from the standalone statements. Returns use average balances.
P/E 24.2 is at the 88th percentile of its own 9.4-year range
(median 13.2, low 6.5, high 47.9).
P/B 0.77 is at the 2th percentile (median 1.52).
Monthly. Market cap from split-adjusted price; profit and book value as reported by that month. A low percentile means cheap versus its own history, not cheap versus peers.
| Period | 532384 | Nifty 50 | Difference |
|---|---|---|---|
| 1 week | -2.0% | -2.8% | +0.8 pts |
| 1 month | +0.5% | -6.8% | +7.3 pts |
| 3 months | -18.6% | -7.6% | -11.0 pts |
| 3 years | -39.5% | +14.2% | -53.7 pts |
| 5 years | -50.6% | +27.9% | -78.5 pts |
Red flags
F-score 4 of 8| explain | Receivables outrunning sales Receivables grew 14% vs sales -18% in 2026 |
| look | Profit leans on other income Other income was 97% of pre-tax profit in 2026 |
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.
Latest quarter
Jun 2026Sales ₹9 Cr -28.3% vs Jun 2025.
Net loss ₹0 Cr.
Activity
Compare| Company | Mcap (Cr) | P/E | ROCE |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | 447,476 | 35.4 | 20.5 % |
| Divis Laboratories Ltd | 250,363 | 84.0 | 22.0 % |
| Torrent Pharmaceuticals Ltd | 186,152 | 83.4 | 15.2 % |
| Zydus Lifesciences Ltd | 119,750 | 24.6 | 21.1 % |
| Cipla Ltd | 111,430 | 31.1 | 15.5 % |
| Laurus Labs Ltd | 106,928 | 97.8 | 17.8 % |
| Mankind Pharma Ltd | 105,120 | 49.3 | 13.5 % |
| Dr Reddys Laboratories Ltd | 104,494 | 32.4 | 13.0 % |
| Aurobindo Pharma Ltd | 97,682 | 25.8 | 12.9 % |
| Lupin Ltd | 93,840 | 15.8 | 29.9 % |
| Glenmark Pharmaceuticals Ltd | 68,905 | 22.1 | 39.8 % |
| Alkem Laboratories Ltd | 62,772 | 27.6 | 21.2 % |
| Biocon Ltd | 61,439 | 84.5 | 3.61 % |
| Abbott India Ltd | 57,949 | 35.9 | 44.8 % |
| Gland Pharma Ltd | 49,333 | 43.1 | 15.1 % |
No bulk or block deals on record.
No corporate actions on record.
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.
Quick answers
What is the market cap of Tyche Industries Ltd?
Tyche Industries Ltd (532384) has a market capitalisation of Rs 108 Cr. at the 2026-10-01 close.
What is the P/E ratio of Tyche Industries Ltd?
Tyche Industries Ltd trades at a P/E of 24.4 on trailing twelve-month profit, at the 2026-10-01 close.
What were Tyche Industries Ltd's latest quarterly results?
In the Jun 2026 quarter, Tyche Industries Ltd sales was Rs 9 Cr (-28.3% vs Jun 2025) with a net loss of Rs 0 Cr.